MZT(SH:688355)2025-04-28 15:20Revenue and Profit - Revenue for Q1 2025 was CNY 117,194,189.06, a decrease of 4.01% compared to CNY 122,087,464.59 in the same period last year[4]. - Net profit attributable to shareholders decreased by 19.77% to CNY 13,202,542.30 from CNY 16,456,220.62 year-on-year[4]. - The net profit for Q1 2025 was CNY 13,174,628.29, a decrease of 19.0% compared to CNY 16,456,220.62 in Q1 2024[22]. - Operating profit for Q1 2025 was CNY 13,689,440.84, down from CNY 16,808,701.75 in the same period last year, reflecting a decline of 18.5%[21]. - The company reported a total comprehensive income of CNY 11,222,380.82 for Q1 2025, down from CNY 17,732,704.10 in Q1 2024, a decline of 36.6%[23]. Cash Flow and Assets - Operating cash flow net amount surged by 446.35% to CNY 20,896,734.92, primarily due to reduced payments for raw materials compared to the previous year[4][8]. - The net cash flow from operating activities for Q1 2025 was CNY 20,896,734.92, significantly higher than CNY 3,824,782.13 in Q1 2024[27]. - Cash and cash equivalents increased to RMB 198,993,355.86 from RMB 117,869,439.41, representing a growth of 68.8%[13]. - The cash and cash equivalents at the end of Q1 2025 amounted to CNY 196,793,081.11, compared to CNY 227,511,569.94 at the end of Q1 2024, indicating a decrease of 13.5%[27]. - Current assets as of March 31, 2025, totaled RMB 881,489,241.77, an increase from RMB 869,283,247.99 as of December 31, 2024[14]. - Total assets at the end of the reporting period were CNY 1,325,964,598.32, a slight increase of 0.1% from CNY 1,324,687,150.51 at the end of the previous year[5]. - Total assets as of March 31, 2025, were RMB 1,325,964,598.32, slightly up from RMB 1,324,687,150.51[15]. Shareholder Equity and Earnings - Shareholders' equity attributable to shareholders increased by 1.03% to CNY 1,096,058,945.77 from CNY 1,084,901,470.58[5]. - The company's equity attributable to shareholders increased to RMB 1,096,058,945.77 from RMB 1,084,901,470.58, reflecting a growth of 1.3%[17]. - The weighted average return on equity decreased by 0.33 percentage points to 1.21%[5]. - The basic and diluted earnings per share were both CNY 0.11, down 15.38% from CNY 0.13[4]. - The basic and diluted earnings per share for Q1 2025 were both CNY 0.11, compared to CNY 0.13 in Q1 2024, reflecting a decrease of 15.4%[23]. Costs and Expenses - Total operating costs for Q1 2025 were RMB 82,321,808.45, down from RMB 87,007,476.28 in Q1 2024, reflecting a cost reduction of approximately 5.8%[20]. - The company incurred a financial expense of CNY -6,584,289.64 in Q1 2025, contrasting with a financial expense of CNY 2,587,957.12 in Q1 2024[21]. Research and Development - R&D investment totaled CNY 16,254,553.32, representing 13.87% of revenue, an increase of 4.51 percentage points year-on-year[5][8]. - Research and development expenses increased to CNY 16,254,553.32 in Q1 2025, up 42.0% from CNY 11,428,406.55 in Q1 2024[21]. Non-Recurring Gains - The company reported a non-recurring gain of CNY 3,812,374.75, primarily from government subsidies and other non-operating income[6][7]. Future Outlook - Future outlook includes potential market expansion and new product development strategies, although specific figures were not disclosed in the current report[12].